Abstract
Brodalumab is a human monoclonal antibody that inhibits interleukin-17 (IL-17) pathway by binding to IL-17 receptor. In clinical trials, a PASI75 resp......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
